Tag: rifampin-resistant tuberculosis

Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]

Oral BPaLM regimen is noninferior to standard of care for rifampin-resistant tuberculosis

byBryant Limand1 others

January 4, 2023

1. A 24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) resulted in lower mortality, treatment failure, and discontinuation compared ...

Quick Take: Discovery and validation of a prognostic proteomic signature for tuberculosis progression

Two bedaquiline-containing regimens had superior efficacy and safety profiles for treatment of rifampin-resistant tuberculosis

byJessie Willisand1 others

December 7, 2022

1. Compared to a 9-month injectable-containing (control) regimen, both bedaquiline-containing oral regimens had more favourable outcomes, such as negative cultures. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result